Bruce Ponder

The Bioscience Investment Trust Plc (formerly 3i Bioscience Investment Trust) provides financial and investment services. It aims to achieve long-term capital growth by investing in life science and healthcare companies in which value growth is expected to occur through the development or application of technology. The company invests in companies including Amgen, Inc., Gilead Science, Inc., Align Technology, Inc., Acambis Plc, Shire Pharmaceuticals Group Plc, Celgene Corp., Protein Design Labs, Inc., Alizyme Plc, Gyrus Group Plc and Advanced Neuromudulation Systems, Inc. Bioscience Investment Trust Plc is headquartered in London, UK.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.